References
- Eaton S, Zani A, Pierro A, De Coppi P. Stem cells as a potential therapy for necrotizing- enterocolitis. Expert Opin Biol Ther. 2013;13:1683–1689. doi:https://doi.org/10.1517/14712598.2013.849690.
- Moak JP. Supraventricular tachycardia in the neonate and infant. Prog Pediatr Cardiol. 2000;11:25–38.
- Nakip G, Sajwani S, Abusalah Z, Abdallah A, Ibrahim N, Fattah A, Bussani R, Calcaterra V, Pelizzo G. Recurrent supraventricular tachycardia and necrotizing enterocolitis: A causative role or a simple association? A case report and literature review. Pediatr Rep. 2018;10:7636. doi:https://doi.org/10.4081/pr.2018.7636.
- Tayman C, Uckan D, Kilic E, Ulus AT, Tonbul A, Murat Hirfanoglu I, Helvacioglu F, Haltas H, Koseoglu B, Tatli MM, et al. Mesenchymal stem cell therapy in necrotizing enterocolitis: a rat study. Pediatr Res. 2011;70:489–494.
- Weil BR, Markel TA, Herrmann JL, Abarbanell AM, Meldrum D. Mesenchymal stem cells enhance the viability and proliferation of human fetal intestinal epithelial cells following hypoxic injury via paracrine mechanisms. Surgery. 2009;146:190–197. doi:https://doi.org/10.1016/j.surg.2009.03.031.
- Hajivassiliou CA, Pitkin J. Recurrent necrotizing enterocolitis associated with episodes of supraventricular tachycardia. J Pediatr Surg. 1998;33:1569–1570.
- Drucker NA, McCulloh CJ, Li B, Pierro A, Besner GE, Markel TA. Stem cell therapy in necrotizing enterocolitis: Current state and future directions. Semin Pediatr Surg. 2018;27:57–64. doi:https://doi.org/10.1053/j.sempedsurg.2017.11.011.
- Allers C, Sierralta WD, Neubauer S, Rivera F, Minguell JJ, Conget PA. Dynamic of distribution of human bone marrow-derived mesenchymal stem cells after transplantation into adult unconditioned mice. Transplantation. 2004;78:503–508. doi:https://doi.org/10.1097/01.TP.0000128334.93343.B3.
- Lin PW, Nasr TR, Stoll BJ. Necrotizing enterocolitis: recent scientific advances in pathophysiology and prevention. Semin Perinatol. 2008;32:70–82. doi:https://doi.org/10.1053/j.semperi.2008.01.004.
- Doster DL, Jensen AR, Khaneki S, Markel TA. Mesenchymal stromal cell therapy for the treatment of intestinal ischemia: defining the optimal cell isolate for maximum therapeutic benefit. Cytotherapy. 2016;18:1457–1470. doi:https://doi.org/10.1016/j.jcyt.2016.08.001.
- Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM, Fike JR, Lee HO, Pfeffer K, Lois C, Morrison SJ, Alvarez-Buylla A. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature. 2003;425:968–973. doi:https://doi.org/10.1038/nature02069.